Holen Sie sich die Stockscreener-App
20.85
0.53%
0.11
Schlusskurs vom Vortag:
$20.74
Offen:
$20.5
24-Stunden-Volumen:
279.62K
Relative Volume:
1.17
Marktkapitalisierung:
$1.95B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+4.15%
1M Leistung:
+1.76%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$20.50
$21.41
1-Wochen-Bereich:
$19.41
$22.51
52-Wochen-Spanne:
$19.41
$27.00
Kardigan Inc Stock (KARD) Company Profile
Compare KARD vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KARD
Kardigan Inc
|
20.85 | 1.89B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Kardigan Inc Aktie (KARD) Neueste Nachrichten
Will KARD be a Portfolio Killer in August? - Zacks Investment Research
Inside cardiovascular biotech Kardigan’s June IPO - CFO Brew
Kardigan Q2 Results: EPS misses estimates by 549.3% - scanx.trade
Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates - BioSpace
Kardigan Inc. Announces Q2 2026 Financial Results and Clinical Trial Updates - Kalkine Media
Kardigan Q2 Per-Share Loss Narrows - marketscreener.com
Kardigan, Inc. 2Q 2026: Net loss $116.2M, EPS $(4.61) — 10-Q Summary - TradingView
Earnings Flash (KARD) Kardigan Posts Q2 Loss $4.61 a Share - marketscreener.com
Kardigan: Q2 Earnings Snapshot - AOL.com
Kardigan, Inc. (NASDAQ:KARD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Kardigan reports Q2 2026 net loss $116.2M, cash $660.7M after IPO - TradingView
Press Release: Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates - Moomoo
Kardigan Ord Shs (KARD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Kardigan (KARD) Institutional Ownership 2026 $KARD - marketbeat.com
KARD: NADetailed Earnings Estimates - Zacks Investment Research
KARD|Kardigan Ord Shs|Price:21.150|Chg%:+0.410 - TradingKey
Kardigan, Inc. Revenue Breakdown – NASDAQ:KARD - TradingView
Latest KARD ETF News Today | Earnings, Events & Price Alerts - Intellectia AI
Kardigan, Inc. (KARD) stock price, news, quote and history - Yahoo Finance UK
Price to earnings ratio of Kardigan, Inc. – NASDAQ:KARD - TradingView
Price to earnings ratio of Kardigan, Inc. – BOATS:KARD - TradingView
Kardigan, Inc. (NASDAQ:KARD) Short Interest Up ∞ in June - MarketBeat
Hrtg Pv, L.p. Net Worth (2026) - GuruFocus
Kevin Anthony Kelly Net Worth (2026) - GuruFocus
Schf Cif 2024, L.p. Net Worth (2026) - GuruFocus
Keith Bryon Johnson Net Worth (2026) - GuruFocus
Kardigan, Inc.: Target Price Consensus and Analysts Recommendations | KARD | US4859251013 - marketscreener.com
Kardigan, Inc.: Revenue and Earnings Analysts Forecasts Revisions | KARD | US4859251013 - marketscreener.com
A Quick Look at Today's Ratings for Kardigan(KARD.US), With a Forecast Between $37 to $51 - Moomoo
Kardigan (KARD) grants 20,706 RSUs tied to Perceptive-linked director pay - Stock Titan
KARD Initiated Coverage by TD Cowen -- Price Target Announced at $46 - GuruFocus
KARD News & Events - Intellectia AI
TD Cowen initiates Kardigan stock with buy rating on cardiology pipeline - Investing.com UK
KARD Initiated Coverage by Leerink Partners -- Rating Outperform - GuruFocus
Kardigan (KARD) Stock Forecast and Price Target 2026 $KARD - MarketBeat
Jefferies initiates Kardigan stock with buy rating on cardiology pipeline By Investing.com - Investing.com Nigeria
KARD Initiated Coverage by JP Morgan -- Price Target Set at $51. - GuruFocus
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Jefferies Initiates Kardigan at Buy With $40 Price Target - marketscreener.com
TD Cowen Initiates Kardigan(KARD.US) With Buy Rating, Announces Target Price $46 - Moomoo
TD Cowen initiates Kardigan stock with buy rating on cardiology pipeline By Investing.com - Investing.com India
JPMorgan initiates Kardigan stock with overweight on pipeline By Investing.com - Investing.com Nigeria
JPMorgan initiates Kardigan stock with overweight on pipeline - Investing.com UK
Jefferies initiates Kardigan stock with buy rating on cardiology pipeline - Investing.com
Kardigan, Inc. Common Stock (NASDAQ: KARD) Share Price, KARD Stock News, KARD Share Price & Updates - Kalkine
CapEx per share of Kardigan, Inc. – NASDAQ:KARD - TradingView
Total common shares outstanding of Kardigan, Inc. – NASDAQ:KARD - TradingView
Average basic shares outstanding of Kardigan, Inc. – BOATS:KARD - TradingView
Kardigan, Inc. Balance Sheet – BOATS:KARD - TradingView
Equity in earnings of Kardigan, Inc. – NASDAQ:KARD - TradingView
EBIT of Kardigan, Inc. – NASDAQ:KARD - TradingView
Finanzdaten der Kardigan Inc-Aktie (KARD)
Es liegen keine Finanzdaten für Kardigan Inc (KARD) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Kardigan Inc-Aktie (KARD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BERNS PAUL L | Director |
Jun 22 '26 |
Buy |
16.00 |
1,250,000 |
20,000,000 |
15,042,035 |
| ARCH Venture Partners XIII, LL | Director |
Jun 22 '26 |
Buy |
16.00 |
1,250,000 |
20,000,000 |
15,042,035 |
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):